Allergy

Rebecca Rosenberger discusses allergic and non-allergic triggers, and how patients with food allergies can avoid allergic reactions through the winter season.

Allergists discuss the differing opinions of allergies and optimizing patient care during the COVID-19 pandemic.

Investigators recommended the development and validation of a screening tool for FAA that transcends the current food allergy-specific measures.

Dr. Mustafa speaks on new data related to peanut allergy and Palforzia therapy that were presented at the most recent ACAAI session.

Investigators reported that the medication was safe for patients with moderate-to-severe atopic dermatitis regardless of the presence of allergic comorbidities.

Data from the LIBERTY AD ADOL trial showed that adolescent patients with moderate-to-severe atopic dermatitis treated with the biologic reported decreases in total and allergen-specific IgE levels for cat dander, peanuts, and more.

Investigators report that the skin condition mediated the association between a a interleukin-4 receptor agonist variant and food allergy.

Investigators believe these data have the potential to be targeted in new drug therapies for the reduction of allergic rhinitis symptoms.

Cohen details some of the diagnostic criteria for anaphylaxis in pediatric populations, differences in symptoms among children and adolescents, and the virtues of epinephrine.

Dr. Hernandez-Trujilo speaks of her personal history with food allergy, and what she recommends for families and expecting parents in the management of pediatric food allergy.

Prior to the investigation, peanut allergy was often linked to high rates of anaphylaxis, with its prevalence in children and adolescents surpassing that found in adult patients.

Investigators call for pollen monitoring that provides free, continuous, real‐time pollen data representative for any given region.

Additionally, investigators believe epidermal impairment in the skin of children with atopic dermatitis could contribute to the development of allergic sensitization.

Investigators believe these findings can help identify high-risk groups and prevent exacerbations through tailored treatments.

An Australian study used data consistent with international literature on the subject of de-labeling penicillin for low-risk allergy patients.

Investigators report that few medical schools in Europe consider allergology to be an important area of study, resulting in a lack of knowledge regarding certain allergy practices.

In an interview with HCPLive, Rosenberger mentioned that every conversation with a patient is an opportunity to educate them on their potential allergies and treatment methods, especially at a time when concerns regarding the delta variant are prominent.

Investigators believe the ALDORADO trial could properly diagnose the accuracy of open food challenges in comparison to the traditionally used double-blind placebo-controlled food challenge in pediatric patients with food allergies.

Investigators report that the small number of adverse events from the vaccine were successfully treated, with the remaining participants experiencing no allergic responses.

The investigative team in Canada found that pre-pregnancy weight may possibly influence a child’s risk of developing pediatric allergic diseases.

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators found that children with antibiotic allergy labels have longer hospital stays and increased symptoms of allergic reaction.

Investigators link early atopic manifestations and other complications to tree nut allergy, which account for most of all food related deaths by anaphylaxis.

Staff from schools across the United Kingdom express desire for enhanced staff preparedness and internal allergy policy review after being surveyed by investigators.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.

A new multi-year study shows that the immunotherapy increases tolerance of peanut products in patients with allergies.

Researchers report antibody responses in kidney transplant recipients and the impact of specific regiments utilized by select patients.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.